Changing perceptions of lung cancer treatment In lung cancer ... Forewarned is forearmed Reaching for the pinnacle ‘gold standard’ of cancer screening is a complicated task.

Approval of Nucala marks the first biologic approved for chronic obstructive pulmonary disease patients with blood eosinophil ...

In patients with lung cancer, more patients managed with current vs. more intensive surveillance guidelines for small ...

A novel screening approach developed by physicians at the Lewis Katz School of Medicine at Temple University shows ...

A therapy at the center of their $22 billion alliance failed to extend survival in a type of lung tumor, leading the ...

She couldn’t even take a full breath when I talked to her, she takes these little panting breaths,” ex-brother-in-law Shaun ...

SMMT's HARMONi trial shows PFS benefits for ivonescimab in EGFR-mutant NSCLC, but lack of proven overall survival raises ...

COPD is a group of progressive lung diseases that ... of the GOLD classification. The GOLD classification is used to determine COPD severity and help form a treatment plan. This is based on ...

New tools, treatment options, and precision medicine developments are leading to better quality of life and survival for ...

Insilico plans late-stage trials for rentosertib following positive mid-stage safety and efficacy data for idiopathic ...

GSK’s Nucala receives US FDA approval for use in adults with chronic obstructive pulmonary disease: London, UK Saturday, May 24, 2025, 11:00 Hrs [IST] GSK plc announced that the ...

Sir H N Reliance Foundation Hospital launches advanced lung disease clinic to fight pulmonary disorders: Our Bureau, Mumbai Wednesday, May 28, 2025, 16:30 Hrs [IST] In a significa ...